HC Wainwright cuts Ionis Pharma price target to $100
HC Wainwright & Co. lowered its Ionis Pharmaceuticals price target to $100.00 a share from $115.00, while maintaining a Buy rating, according to TradingView News via Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.